Karin Filipsson
Overview
Explore the profile of Karin Filipsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stepien K, Langendonk J, Dao M, Gomes D, Douillard C, Filipsson K, et al.
J Inherit Metab Dis
. 2023 Dec;
47(6):1239-1259.
PMID: 38069502
An increasing number of women with urea cycle disorders (UCDs) are reaching child-bearing age and becoming pregnant. Improved diagnostics and increased awareness of inherited metabolic diseases has also led to...
2.
Sofizadeh S, Imberg H, Olafsdottir A, Ekelund M, Dahlqvist S, Hirsch I, et al.
Diabetes Ther
. 2019 Sep;
10(6):2115-2130.
PMID: 31564026
Introduction: The effects of the GLP-1 analogue liraglutide on time in hypoglycaemia, time in hyperglycaemia, and time in range for type 2 diabetes patients initially treated with multiple daily insulin...
3.
Hals I, Fiskvik Fleiner H, Reimers N, Astor M, Filipsson K, Ma Z, et al.
Diabetes Obes Metab
. 2019 Jun;
21(10):2219-2227.
PMID: 31148332
Aims: To compare outcomes of glucagon-stimulated C-peptide tests (GSCTs) in people with latent autoimmune diabetes in adults (LADA) after a 21-month intervention with either insulin or the dipeptidyl peptidase-4 inhibitor...
4.
Dahlqvist S, Ahlen E, Filipsson K, Gustafsson T, Hirsch I, Tuomilehto J, et al.
BMJ Open Diabetes Res Care
. 2018 Mar;
6(1):e000464.
PMID: 29527308
Objective: To evaluate variables associated with hemoglobin A1c (HbA1c) and weight reduction when adding liraglutide to persons with type 2 diabetes treated with multiple daily insulin injections (MDI). Research Design...
5.
Andersson L, Nicholas L, Filipsson K, Sun J, Medina A, Al-Majdoub M, et al.
FEBS Lett
. 2016 Dec;
590(23):4242-4251.
PMID: 27943300
Glycogen metabolism in β-cells may affect downstream metabolic pathways controlling insulin release. We examined glycogen metabolism in human islets and in the rodent-derived INS-1 832/13 β-cells and found them to...
6.
Lind M, Hirsch I, Tuomilehto J, Dahlqvist S, Ahren B, Torffvit O, et al.
BMJ
. 2015 Oct;
351:h5364.
PMID: 26512041
Study Question: What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple daily insulin injections? Methods: The study...
7.
Geidenstam N, Spegel P, Mulder H, Filipsson K, Ridderstrale M, Danielsson A
Obesity (Silver Spring)
. 2014 Aug;
22(11):2388-95.
PMID: 25132155
Objective: While impaired glucose tolerance diagnosed by the oral glucose tolerance test (OGTT) is a common trait in obese individuals, less is known about changes in levels of other metabolites....
8.
Spegel P, Ekholm E, Tuomi T, Groop L, Mulder H, Filipsson K
Diabetes
. 2012 Nov;
62(2):653-61.
PMID: 23139355
Mutations in the gene encoding glucokinase (GCK) cause a mild hereditary form of diabetes termed maturity-onset diabetes of the young (MODY)2 or GCK-MODY. The disease does not progress over time,...
9.
Neary N, Small C, Druce M, Park A, Ellis S, Semjonous N, et al.
Endocrinology
. 2005 Sep;
146(12):5120-7.
PMID: 16150917
Peptide YY (PYY) and glucagon like peptide (GLP)-1 are cosecreted from intestinal L cells, and plasma levels of both hormones rise after a meal. Peripheral administration of PYY(3-36) and GLP-1(7-36)...
10.
Andersson U, Filipsson K, Abbott C, Woods A, Smith K, Bloom S, et al.
J Biol Chem
. 2004 Jan;
279(13):12005-8.
PMID: 14742438
AMP-activated protein kinase (AMPK) is the downstream component of a protein kinase cascade that acts as an intracellular energy sensor maintaining the energy balance within the cell. The finding that...